$CRCW
Crypto Co

2024 Q3 Form 10-Q Financial Statement

#000149315224032964 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $10.30K $9.841K
YoY Change -91.71% -90.77%
Cost Of Revenue $7.361K $7.733K
YoY Change -50.6% -93.41%
Gross Profit $2.938K $2.107K
YoY Change -97.31% -119.68%
Gross Profit Margin 28.53% 21.41%
Selling, General & Admin $683.3K
YoY Change 55.15%
% of Gross Profit 32430.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.84K
YoY Change
% of Gross Profit 514.48%
Operating Expenses $28.28K $694.1K
YoY Change -92.33% 53.83%
Operating Profit -$25.34K -$692.0K
YoY Change -90.24% 49.81%
Interest Expense -$193.2K
YoY Change -155.77%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$102.1K -$885.2K
YoY Change -71.54% 13.12%
Income Tax
% Of Pretax Income
Net Earnings -$102.1K -$885.2K
YoY Change -71.54% 13.12%
Net Earnings / Revenue -991.8% -8995.31%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.982B shares 1.071B shares
Diluted Shares Outstanding 2.008B shares 1.982B shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.39K
YoY Change 77.55%
Cash & Equivalents $6.662K $31.39K
Short-Term Investments
Other Short-Term Assets $12.13K
YoY Change -36.56%
Inventory
Prepaid Expenses $3.032K $12.13K
Receivables
Other Receivables
Total Short-Term Assets $9.694K $43.51K
YoY Change -59.92% 18.25%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $746.4K $740.5K
YoY Change 0.8% 0.0%
Intangibles $509.2K $509.2K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.256M $1.250M
YoY Change -2.07% -3.35%
TOTAL ASSETS
Total Short-Term Assets $9.694K $43.51K
Total Long-Term Assets $1.256M $1.250M
Total Assets $1.265M $1.293M
YoY Change -3.15% -2.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.105M
YoY Change 19.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $2.822M
YoY Change 17.19%
Total Short-Term Liabilities $6.037M $5.927M
YoY Change 19.0% 18.59%
LONG-TERM LIABILITIES
Long-Term Debt $12.98K
YoY Change -90.64%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $12.98K
YoY Change -90.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.037M $5.927M
Total Long-Term Liabilities $12.98K
Total Liabilities $6.050M $5.940M
YoY Change 16.09% 15.64%
SHAREHOLDERS EQUITY
Retained Earnings -$47.74M -$47.24M
YoY Change 9.86% 9.6%
Common Stock $42.96M $42.59M
YoY Change 8.61% 8.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.785M -$4.647M
YoY Change
Total Liabilities & Shareholders Equity $1.265M $1.293M
YoY Change -3.15% -2.75%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$102.1K -$885.2K
YoY Change -71.54% 13.12%
Depreciation, Depletion And Amortization $10.84K
YoY Change
Cash From Operating Activities -$257.2K
YoY Change -15.13%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 266.7K
YoY Change -12.28%
NET CHANGE
Cash From Operating Activities -257.2K
Cash From Investing Activities
Cash From Financing Activities 266.7K
Net Change In Cash 9.510K
YoY Change 841.58%
FREE CASH FLOW
Cash From Operating Activities -$257.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-4212105
dei Entity Address Address Line1
EntityAddressAddressLine1
23823 Malibu Road
dei Entity Address Address Line2
EntityAddressAddressLine2
# 50477
dei Entity Address City Or Town
EntityAddressCityOrTown
Malibu
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90265
dei City Area Code
CityAreaCode
(424)
dei Local Phone Number
LocalPhoneNumber
228-9955
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001688126
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
usd
CY2024Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2024Q2 CRCW Loss On Sale Of Property Plant Equipment
LossOnSaleOfPropertyPlantEquipment
usd
CRCW Loss On Sale Of Property Plant Equipment
LossOnSaleOfPropertyPlantEquipment
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CRCW Financing Costs Associated With Convertible Debt
FinancingCostsAssociatedWithConvertibleDebt
usd
CRCW Issuance Of Common Stock For Acquisition
IssuanceOfCommonStockForAcquisition
usd
CRCW Issuance Of Common Stock For Acquisition
IssuanceOfCommonStockForAcquisition
usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
dei Entity File Number
EntityFileNumber
000-55726
dei Entity Registrant Name
EntityRegistrantName
THE CRYPTO COMPANY
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1981881172 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72970 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
30317 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
103287 usd
CY2023Q4 us-gaap Goodwill
Goodwill
740469 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
530837 usd
CY2023Q4 us-gaap Assets
Assets
1374593 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2678883 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
2697085 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2506443 usd
CY2024Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
125000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5927011 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5185326 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
125000 usd
CY2024Q2 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
12979 usd
CY2023Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
13333 usd
CY2024Q2 us-gaap Liabilities
Liabilities
5939990 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5323659 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1981881172 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1981881172 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
565709873 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
565709873 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1981881 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
565321 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
40609865 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39932216 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47238583 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44446603 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4646837 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3949066 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1293153 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1374593 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9841 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106610 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7733 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
117314 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
2107 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-10704 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
243823 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
320500 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10833 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10833 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21666 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
694143 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
451252 usd
us-gaap Operating Expenses
OperatingExpenses
2415020 usd
us-gaap Operating Expenses
OperatingExpenses
1293670 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-692036 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-461956 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2398631 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1245137 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
25775 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
25775 usd
CRCW Loss On Sale Of Property Plant Equipment
LossOnSaleOfPropertyPlantEquipment
31000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
193192 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
346402 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
393349 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2317315 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-885228 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-782583 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2791981 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3567677 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-885228 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-782583 usd
us-gaap Net Income Loss
NetIncomeLoss
-2791981 usd
us-gaap Net Income Loss
NetIncomeLoss
-3567677 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1981881172 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1981881172 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35731866 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35731866 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1442211647 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1442211647 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30444263 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30444263 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3059440 usd
CY2023Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.00
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
386561 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2031499 usd
CRCW Stock Issued During Period Value Loan Payments
StockIssuedDuringPeriodValueLoanPayments
377346 usd
us-gaap Net Income Loss
NetIncomeLoss
-3567677 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3806711 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
332732.00 usd
us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
3000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
17998 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1740480 usd
us-gaap Net Income Loss
NetIncomeLoss
-2791981 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4646837 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4646837 usd
us-gaap Net Income Loss
NetIncomeLoss
-2791981 usd
us-gaap Net Income Loss
NetIncomeLoss
-3567677 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
21666 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
21666 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1706700 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
506479 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17998 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2031499 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-31000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-17834 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-62200 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
426043 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
324203 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-601739 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-590630 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
187062 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
560155 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
659767 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
560155 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
497705 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41584 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-92924 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31386 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17682 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
366511 usd
CY2024Q2 us-gaap Cash
Cash
31386 usd
us-gaap Net Income Loss
NetIncomeLoss
-2791981 usd
CRCW Working Capital
WorkingCapital
-4646837 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47238583 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_z6YOpPFBrPu1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zw4PjbYfrwR5">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these condensed consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant estimates and assumptions include but are not limited to the valuation allowances of deferred taxes, and share-based compensation expenses. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Goodwill Gross
GoodwillGross
1349457 usd
CY2024Q2 us-gaap Goodwill
Goodwill
740469 usd
CY2024Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
650000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
54166 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21666 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
125000 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
125000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2281429 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.26
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2281429 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.26
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y9M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2281429 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.26
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y9M
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
us-gaap Payments For Rent
PaymentsForRent
0 usd
us-gaap Payments For Rent
PaymentsForRent
0 usd
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-032964-index-headers.html Edgar Link pending
0001493152-24-032964-index.html Edgar Link pending
0001493152-24-032964.txt Edgar Link pending
0001493152-24-032964-xbrl.zip Edgar Link pending
crcw-20240630.xsd Edgar Link pending
ex10-1.htm Edgar Link pending
ex10-1_001.jpg Edgar Link pending
ex10-1_002.jpg Edgar Link pending
ex10-1_003.jpg Edgar Link pending
ex10-1_004.jpg Edgar Link pending
ex10-1_005.jpg Edgar Link pending
ex10-2.htm Edgar Link pending
ex10-2_001.jpg Edgar Link pending
ex10-2_002.jpg Edgar Link pending
ex10-2_003.jpg Edgar Link pending
ex10-2_004.jpg Edgar Link pending
ex10-2_005.jpg Edgar Link pending
ex10-2_006.jpg Edgar Link pending
ex10-2_007.jpg Edgar Link pending
ex10-2_008.jpg Edgar Link pending
ex10-2_009.jpg Edgar Link pending
ex10-2_010.jpg Edgar Link pending
ex10-2_011.jpg Edgar Link pending
ex10-2_012.jpg Edgar Link pending
ex10-2_013.jpg Edgar Link pending
ex10-2_014.jpg Edgar Link pending
ex10-2_015.jpg Edgar Link pending
ex10-2_016.jpg Edgar Link pending
ex10-2_017.jpg Edgar Link pending
ex10-2_018.jpg Edgar Link pending
ex10-2_019.jpg Edgar Link pending
ex10-2_020.jpg Edgar Link pending
ex10-2_021.jpg Edgar Link pending
ex10-2_022.jpg Edgar Link pending
ex10-2_023.jpg Edgar Link pending
ex10-2_024.jpg Edgar Link pending
ex10-2_025.jpg Edgar Link pending
ex10-3.htm Edgar Link pending
ex10-3_001.jpg Edgar Link pending
ex10-3_002.jpg Edgar Link pending
ex10-3_003.jpg Edgar Link pending
ex10-3_004.jpg Edgar Link pending
ex10-3_005.jpg Edgar Link pending
ex10-3_006.jpg Edgar Link pending
ex10-3_007.jpg Edgar Link pending
ex10-3_008.jpg Edgar Link pending
ex10-3_009.jpg Edgar Link pending
ex10-3_010.jpg Edgar Link pending
ex10-3_011.jpg Edgar Link pending
ex10-3_012.jpg Edgar Link pending
ex10-3_013.jpg Edgar Link pending
ex10-3_014.jpg Edgar Link pending
ex10-3_015.jpg Edgar Link pending
ex10-3_016.jpg Edgar Link pending
ex10-3_017.jpg Edgar Link pending
ex10-3_018.jpg Edgar Link pending
ex10-3_019.jpg Edgar Link pending
ex10-3_020.jpg Edgar Link pending
ex10-3_021.jpg Edgar Link pending
ex10-3_022.jpg Edgar Link pending
ex10-3_023.jpg Edgar Link pending
ex10-3_024.jpg Edgar Link pending
ex10-7.htm Edgar Link pending
ex10-7_001.jpg Edgar Link pending
ex10-7_002.jpg Edgar Link pending
ex10-7_003.jpg Edgar Link pending
ex10-7_004.jpg Edgar Link pending
ex10-7_005.jpg Edgar Link pending
ex10-7_006.jpg Edgar Link pending
ex10-7_007.jpg Edgar Link pending
ex10-7_008.jpg Edgar Link pending
ex10-7_009.jpg Edgar Link pending
ex10-7_010.jpg Edgar Link pending
ex10-7_011.jpg Edgar Link pending
ex10-7_012.jpg Edgar Link pending
ex10-7_013.jpg Edgar Link pending
ex10-7_014.jpg Edgar Link pending
ex10-7_015.jpg Edgar Link pending
ex10-7_016.jpg Edgar Link pending
ex10-7_017.jpg Edgar Link pending
ex10-7_018.jpg Edgar Link pending
ex10-7_019.jpg Edgar Link pending
ex10-7_020.jpg Edgar Link pending
ex10-7_021.jpg Edgar Link pending
ex10-7_022.jpg Edgar Link pending
ex10-7_023.jpg Edgar Link pending
ex10-7_024.jpg Edgar Link pending
ex10-7_025.jpg Edgar Link pending
ex10-8.htm Edgar Link pending
ex10-8_001.jpg Edgar Link pending
ex10-8_002.jpg Edgar Link pending
ex10-8_003.jpg Edgar Link pending
ex10-8_004.jpg Edgar Link pending
ex10-8_005.jpg Edgar Link pending
ex10-8_006.jpg Edgar Link pending
ex10-8_007.jpg Edgar Link pending
ex10-8_008.jpg Edgar Link pending
ex10-8_009.jpg Edgar Link pending
ex10-8_010.jpg Edgar Link pending
ex10-8_011.jpg Edgar Link pending
ex10-8_012.jpg Edgar Link pending
ex10-8_013.jpg Edgar Link pending
ex10-8_014.jpg Edgar Link pending
ex10-8_015.jpg Edgar Link pending
ex10-8_016.jpg Edgar Link pending
ex10-8_017.jpg Edgar Link pending
ex10-8_018.jpg Edgar Link pending
ex10-8_019.jpg Edgar Link pending
ex10-8_020.jpg Edgar Link pending
ex10-8_021.jpg Edgar Link pending
ex10-8_022.jpg Edgar Link pending
ex10-8_023.jpg Edgar Link pending
ex10-8_024.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
form10-q_htm.xml Edgar Link completed
crcw-20240630_cal.xml Edgar Link unprocessable
crcw-20240630_lab.xml Edgar Link unprocessable
crcw-20240630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
crcw-20240630_pre.xml Edgar Link unprocessable